4-aminoquinoline has been researched along with Malaria, Falciparum in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (10.53) | 18.2507 |
2000's | 4 (21.05) | 29.6817 |
2010's | 12 (63.16) | 24.3611 |
2020's | 1 (5.26) | 2.80 |
Authors | Studies |
---|---|
Chibale, K; Egan, TJ; Kuter, D; Nsumiwa, S; Wittlin, S | 1 |
Aderibigbe, BA; Nqoro, X | 1 |
Gut, J; Kumar, V; Rani, A; Rosenthal, PJ; Singh, A | 1 |
Agarwal, D; Awasthi, SK; Gupta, RD; Singh, S | 1 |
Chauhan, K; Chauhan, PM; Puri, SK; Saxena, JK; Sharma, M; Singh, SV; Srivastava, K; Srivastava, RK | 1 |
Castellà, S; Clos, MV; Fairlamb, AH; Galdeano, C; Gbedema, SY; Jones, DC; Kelly, JM; Muñoz-Torrero, D; Pérez, B; Sola, I; Taylor, MC; Viayna, E; Wright, CW | 1 |
Chibale, K; Egan, TJ; Jurva, U; Masimirembwa, CM; Njoroge, M; Ongarora, DS; Strydom, N; Wicht, K; Wiesner, L; Wittlin, S | 1 |
Callaghan, PS; Combrinck, JM; Dhingra, SK; Egan, TJ; Fidock, DA; Gabryszewski, SJ; Gnädig, NF; Hassett, MR; Henrich, PP; Lee, AH; Lewis, IA; Llinás, M; Musset, L; Roepe, PD; Siriwardana, A | 1 |
Katti, SB; Kondaparla, S; Manhas, A; Puri, SK; Soni, A; Srivastava, K | 1 |
Alumasa, J; de Dios, AC; Ekoue-Kovi, K; Iwaniuk, DP; Roepe, PD; Rosa, N; Whetmore, ED; Wolf, C | 1 |
Biot, C; Dal-Bianco, MP; Filali-Ansary, A; Issifou, S; Kremsner, PG; Lell, B; Mazuir, F; Mombo-Ngoma, G; Ospina Salazar, CL; Ramharter, M; Supan, C; Ter-Minassian, D | 1 |
Bjorkman, A; Cavaco, I; Gil, JP; Msellem, MI; Piedade, R | 1 |
Barho, M; Ortmann, R; Schlitzer, M; Schrader, FC; Steiner, I | 1 |
Khan, SI; Manohar, S; Rawat, DS | 1 |
Casey, GJ; Cowman, AF; Genton, B; Ginny, M; Mueller, I; Reeder, JC; Uranoli, M | 1 |
Björkman, A; Hwaihwanje, I; Kaneko, A; Kobayakawa, T; Mita, T; Osawa, H; Takahashi, N; Tanabe, K; Tsukahara, T | 1 |
Carme, B | 1 |
Adedeji, AA; Falade, AG; Falade, CO; Sowunmi, A | 1 |
Bauchet, J; Hatin, I; Le Bras, J; Legros, F; Trape, JF | 1 |
1 review(s) available for 4-aminoquinoline and Malaria, Falciparum
Article | Year |
---|---|
The antimalarial pipeline--an update.
Topics: Aminoquinolines; Animals; Antimalarials; Clinical Trials as Topic; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Plasmodium falciparum | 2012 |
18 other study(ies) available for 4-aminoquinoline and Malaria, Falciparum
Article | Year |
---|---|
Structure-activity relationships for ferriprotoporphyrin IX association and β-hematin inhibition by 4-aminoquinolines using experimental and ab initio methods.
Topics: Aminoquinolines; Antimalarials; Hemeproteins; Hemin; Humans; Malaria, Falciparum; Models, Molecular; Plasmodium falciparum; Structure-Activity Relationship | 2013 |
4-Aminoquinoline-ferrocene Hybrids as Potential Antimalarials.
Topics: Aminoquinolines; Antimalarials; Drug Evaluation, Preclinical; Ferrous Compounds; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Metallocenes; Parasitic Sensitivity Tests; Patents as Topic; Plasmodium falciparum | 2020 |
Piperazine-linked 4-aminoquinoline-chalcone/ferrocenyl-chalcone conjugates: Synthesis and antiplasmodial evaluation.
Topics: Aminoquinolines; Antimalarials; Chalcone; Chloroquine; Drug Resistance; Ferrous Compounds; HeLa Cells; Humans; Malaria, Falciparum; Piperazines; Plasmodium falciparum | 2017 |
In vitro synergistic interaction of potent 4-aminoquinolines in combination with dihydroartemisinin against chloroquine-resistant Plasmodium falciparum.
Topics: Aminoquinolines; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Malaria, Falciparum; Plasmodium falciparum | 2019 |
Design and synthesis of a new class of 4-aminoquinolinyl- and 9-anilinoacridinyl Schiff base hydrazones as potent antimalarial agents.
Topics: Acridines; Aminoquinolines; Animals; Antimalarials; Chlorocebus aethiops; Hydrazones; Malaria, Falciparum; Male; Mice; Plasmodium falciparum; Schiff Bases; Vero Cells | 2014 |
Synthesis, biological profiling and mechanistic studies of 4-aminoquinoline-based heterodimeric compounds with dual trypanocidal-antiplasmodial activity.
Topics: Aminoquinolines; Animals; Antimalarials; Brain; Cell Line; Dimerization; Hemeproteins; Humans; Malaria, Falciparum; NADH, NADPH Oxidoreductases; Plasmodium falciparum; Rats; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2015 |
Antimalarial benzoheterocyclic 4-aminoquinolines: Structure-activity relationship, in vivo evaluation, mechanistic and bioactivation studies.
Topics: Aminoquinolines; Animals; Antimalarials; Benzene Derivatives; Humans; Malaria; Malaria, Falciparum; Mice; Mice, Inbred C57BL; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship | 2015 |
Evolution of Fitness Cost-Neutral Mutant PfCRT Conferring P. falciparum 4-Aminoquinoline Drug Resistance Is Accompanied by Altered Parasite Metabolism and Digestive Vacuole Physiology.
Topics: Aminoquinolines; Antimalarials; Drug Resistance; Genetic Fitness; Genotype; Humans; Malaria, Falciparum; Mass Spectrometry; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Plasmodium falciparum; Protozoan Proteins; Vacuoles | 2016 |
Antimalarial activity of novel 4-aminoquinolines active against drug resistant strains.
Topics: Aminoquinolines; Animals; Antimalarials; Chlorocebus aethiops; Drug Discovery; Drug Resistance; Humans; Malaria; Malaria, Falciparum; Mice; Parasitic Sensitivity Tests; Plasmodium falciparum; Plasmodium yoelii; Vero Cells | 2017 |
Synthesis and antimalarial activity of new chloroquine analogues carrying a multifunctional linear side chain.
Topics: Aminoquinolines; Animals; Antimalarials; Chloroquine; Inhibitory Concentration 50; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum | 2009 |
Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections.
Topics: Adolescent; Adult; Aminoquinolines; Antimalarials; Clinical Trials, Phase I as Topic; Ferrous Compounds; Humans; Malaria, Falciparum; Male; Metallocenes; Models, Statistical; Plasmodium falciparum; Young Adult | 2012 |
Cytochrome 1A1 and 1B1 gene diversity in the Zanzibar islands.
Topics: Alleles; Aminoquinolines; Antimalarials; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Female; Genetic Variation; Genotype; Geography; Humans; Malaria, Falciparum; Male; Pharmacogenetics; Polymorphism, Genetic; Tanzania; Young Adult | 2012 |
4-aminoquinoline-triazine-based hybrids with improved in vitro antimalarial activity against CQ-sensitive and CQ-resistant strains of Plasmodium falciparum.
Topics: Aminoquinolines; Animals; Antimalarials; Chlorocebus aethiops; Chloroquine; Drug Resistance; Hep G2 Cells; Humans; Malaria, Falciparum; Plasmodium falciparum; Triazines; Vero Cells | 2013 |
Molecular analysis of Plasmodium falciparum from drug treatment failure patients in Papua New Guinea.
Topics: Aminoquinolines; Amodiaquine; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Membrane Proteins; Membrane Transport Proteins; Papua New Guinea; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Treatment Failure | 2004 |
Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea.
Topics: Alleles; Aminoquinolines; Animals; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mutation; Papua New Guinea; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Selection, Genetic; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2006 |
[Antimalarial measures in expatriates in the Congo. Trends 1989-1992].
Topics: Adult; Aminoquinolines; Antimalarials; Child; Child, Preschool; Congo; Ethnicity; Female; Health Knowledge, Attitudes, Practice; Humans; Malaria, Falciparum; Male; Patient Compliance; Phenanthrenes; Surveys and Questionnaires | 1993 |
Comparative clinical characteristics and responses to oral 4-aminoquinoline therapy of malarious children who did and did not develop 4-aminoquinoline-induced pruritus.
Topics: Acute Disease; Adolescent; Aminoquinolines; Animals; Antimalarials; Child; Child, Preschool; Drug Eruptions; Hepatomegaly; Humans; Infant; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Prospective Studies; Pruritus; Treatment Outcome | 2001 |
Susceptibility of Plasmodium falciparum strains to mefloquine in an urban area in Senegal.
Topics: Adolescent; Adult; Aminoquinolines; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Humans; In Vitro Techniques; Infant; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum | 1992 |